Merlin waves his biotechnological wand

April 3, 1998

Merlin Ventures, the biotechnology investment firm set up by academic-turned-entrepreneur Chris Evans, is pumping Pounds 10 million into three of its firms. ReNeuron, set up last year, will get Pounds 5 million for research at the Institute of Psychiatry, part of King's College London, on treatments for strokes, Alzheimer's and Parkinson's disease, and genetic disorders such as Huntingdon's disease.

Microscience, a spin-off of the Royal Postgraduate Medical School, will get Pounds 2.5 million for work on antimicrobial vaccines and drugs. Eurogene will get Pounds 3 million for work on cardiovascular disease at University College London and at Finland's Virtanen Institute.

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments

Most commented

Recent controversy over the future directions of both Stanford and Melbourne university presses have raised questions about the role of in-house publishing arms in a world of commercialisation, impact agendas, alternative facts – and ever-diminishing monograph sales. Anna McKie reports

3 October

Sponsored

Featured jobs

Programme and Delivery Manager

University Of Leeds

Analyst/Programmer

Maynooth University

Occupational Health Manager

University Of The West Of Scotland

Senior Veterinary Epidemiologist

Scotland's Rural College (sruc)